Document is current
Any future updates will be listed below
-
Authors
Khaled, Salma Mawfek
Amro, Iman
Bader, Lina
Woodruff, Peter
Alabdulla, Majid A.
Bellaj, Tarek
Marzouk, Yousri
Hasan, Youssef
Al-Kaabi, Ibrahim M.
Haddad, Peter M.
-
Funding
Funding for this research was provided by:
Qatar University (QUERGCAS-2020-1)
Qatar University (QUERGCAS-2020-1)
Qatar University (QUERGCAS-2020-1)
Qatar University (QUERGCAS-2020-1)
Qatar University (QUERGCAS-2020-1)
Qatar University (QUERGCAS-2020-1)
Qatar University (QUERGCAS-2020-1)
Qatar University (QUERGCAS-2020-1)
- License Information
-
More Information
Article History
Received: 3 October 2021
Accepted: 30 November 2021
First Online: 20 December 2021
Declarations
:
: Qatar University Institutional Review Board (QU-IRB 1338 EA/20) and Hamad Medical Corporation (MRC05-089) approved the study protocol in accordance with standard research protocols and HIPAA. Electronic informed consent was obtained from each respondent.
: Not applicable.
: Professor Haddad reports personal fees from Janssen, Otsuka and New Bridge Pharmaceuticals outside the submitted work.
